Výsledky vyhledávání - "Human Vγ9Vδ2 T lymphocytes"

Akademický článek

Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells

Publikováno v: Frontiers in Immunology, Vol 11 (2020)

Despite recent advances, the eradication of cancers still represents a challenge which justifies the exploration of additional therapeutic strategies such as immunotherapies, including adoptive cell transfers. Human peripheral Vγ9Vδ2 T cells, which

Externí odkaz: https://doaj.org/article/516f763e00b84c25b1d9dd8679850c08

Zobrazit plný text záznamu

Akademický článek

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

Autor: Noémie Joalland, Laura Lafrance, Thibauld Oullier, Séverine Marionneau-Lambot, Delphine Loussouarn, Ulrich Jarry, Emmanuel Scotet

Publikováno v: OncoImmunology, Vol 8, Iss 11 (2019)

Epithelial ovarian cancer (EOC) represents 5% of human gynecologic cancers in the world, is heterogeneous and highly invasive with a dismal prognosis (5 year-survival rate

Externí odkaz: https://doaj.org/article/563c928341d843299e8ecaa2beffc3a6

Zobrazit plný text záznamu

Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells

Autor: Joalland, Noémie, Scotet, Emmanuel

Publikováno v: Frontiers in Immunology
Frontiers in Immunology, 2020, 11, pp.992. ⟨10.3389/fimmu.2020.00992⟩
Frontiers in Immunology, Frontiers, 2020, 11, pp.992. ⟨10.3389/fimmu.2020.00992⟩

International audience; Despite recent advances, the eradication of cancers still represents a challenge which justifies the exploration of additional therapeutic strategies such as immunotherapies, including adoptive cell transfers. Human peripheral

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::26615e6a858743eaab8ba5e500392c3a
https://pubmed.ncbi.nlm.nih.gov/32528477

Zobrazit plný text záznamu

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

Autor: Joalland, Noémie, Lafrance, Laura, Oullier, Thibauld, Marionneau-Lambot, Severine, Loussouarn, Delphine, Jarry, Ulrich, Scotet, Emmanuel

Publikováno v: Oncoimmunology
OncoImmunology
OncoImmunology, Taylor & Francis, 2019, 8 (11), pp.e1649971. ⟨10.1080/2162402X.2019.1649971⟩
OncoImmunology, Vol 8, Iss 11 (2019)
OncoImmunology, 2019, 8 (11), pp.e1649971. ⟨10.1080/2162402X.2019.1649971⟩

International audience; Epithelial ovarian cancer (EOC) represents 5% of human gynecologic cancers in the world, is hetero- geneous and highly invasive with a dismal prognosis (5 year-survival rate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::52042284e237ae8256e6e0e470d76552
http://europepmc.org/articles/PMC6791416

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání